Search

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

… Wednesday, May 16, 2012 Screening lung cancer tumor samples for cancer-causing, or “driver,” genetic mutations can help physicians tailor patients’ treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.

… Thursday, September 18, 2014 Summary The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute. On Tuesday, more than 40 Memorial Sloan Kettering doctors, including President and CEO Craig B. Thompson and Physician-in-Chief

Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.

… Monday, February 1, 2010 Summary Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

… Monday, March 10, 2014 Summary Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors. Memorial Sloan Kettering researchers have shown that tiny particles can be manipulated to act like sponges, taking in drugs

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.

… Friday, April 19, 2019 Summary MSK researchers are using computer algorithms and artificial intelligence to develop a new type of PET imaging. Recently, the first-ever image of a black hole was splashed across front pages and filled up news feeds around the world. The image was made in part thanks to

Read about new targets and tactics for treating acute myeloid leukemia.

… Monday, June 10, 2024 Ever since he was in college, Michael Rosensweig has endured a series of grueling treatments for acute myeloid leukemia (AML) . This kind of blood cancer is relentless. It moves quickly and needs aggressive, often harsh, treatment with chemotherapy , sometimes followed by a bone

As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials.

… Friday, October 1, 2010 Summary As part of a commitment to seek new and better treatments for cancer patients, Memorial Sloan Kettering Cancer Center and Bristol-Myers Squibb are collaborating to bring a potential new cancer drug called iso-fludelone, or KOS-1803, into clinical trials. As part of a commitment

An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.

… Tuesday, December 10, 2024 Summary With more people surviving longer after lung cancer , close management of those who have had successful treatment is more important than ever. MSK’s Lung Cancer Survivorship Program provides regular screening for recurrent cancers or new tumors, as well as guidance

Un programa de MSK ayuda a los sobrevivientes de cáncer pulmonar a mantenerse saludables después de un tratamiento exitoso contra su enfermedad.

… Tuesday, December 10, 2024 Resumen Debido a que más personas sobreviven por más tiempo después de un cáncer pulmonar , el seguimiento cercano de quienes han recibido un tratamiento exitoso es más importante que nunca. El Programa de Sobrevivencia de Cáncer Pulmonar de MSK ofrece exámenes regulares para

Learn how a blood test could someday provide a way to detect cancers at an early stage.

… Friday, October 13, 2023 A blood test that could detect multiple cancers at their earliest stages has long been a dream of the medical community. Now results from a pilot study, published in The Lancet , suggest that a single blood test might identify the presence of more than 50 cancer types . The experimental